AFIAS COVID-19 Neutralizing Antibodies
-Detects directly total neutralizing antibodies to SARS-CoV-2 (not by correlation)
-Based on competitive immunodetection technology
-Reference method : PRNT and cPass ELISA assay
-Clinical sensitivity : 97.3%
-Clinical specificity : 100%
AFIAS-6 is a unique integrated (sample-to-answer) system featuring 6 parallel tests of differing parameters, fast turn-around and high sensitivity, rivaling those of the full-featured systems in commercial labs.
The COVID-19 Neutralizing Ab (nAb) kit is an In-vitro diagnostic kit for simple and quick examination of neutralizing antibody produced in patients recovering from Covid-19 infection and those vaccinated. The kit quickly and accurately tests the presence or absence of a neutralizing antibody against the corona-19 virus. The presence of this antibody can lead to the conclusion the patient has developed immunity against the COVID-19 virus.